Loading...
Diazepam — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Diazepam
2025-Q4
Comprehensive analysis of India’s diazepam export trade — suppliers, buyers, prices, routes, and every shipment record.
71
Shipments
$1.10M
Trade Value
25
Suppliers
35
Buyers
27
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/diazepam
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s diazepam trade — 2025-Q4
KEY TAKEAWAY
Diazepam 2025-Q4 exports total $1.1M across 27 countries, with AJANTA PHARMA LTD commanding 29.1% market share.
TOTAL SHIPMENTS
71
2025-Q4
EXPORT VALUE
$1.1M
FOB USD
TOTAL QUANTITY
27.9M
units shipped
INDIAN SUPPLIERS
25
unique exporters
GLOBAL BUYERS
35
unique importers
DESTINATIONS
27
countries
MEDIAN UNIT PRICE
$0.125
per unit
TOP-5 SHARE
72.3%
of total USD
BRANDED SHARE
53.5%
38 shipments
DOSAGE FORMS
7
product types
6 KEY FINDINGS
1
AJANTA PHARMA LTD is India's #1 Diazepam exporter with $320.3K (29.1% market share).→ §5, Indian Supplier Rankings
2
Diazepam reached 27 countries, with United States as the top destination ($355.1K).→ §4, Global Destination Map
3
Market concentration is moderate (HHI: 1598) — top 10 suppliers control 88.7% of exports.→ §5, Indian Supplier Rankings
4
94.3% of buyers (33 of 35) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Injection dominates (54.3%) across 7 dosage forms.→ §7, Price Benchmarks
6
27 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 AJANTA PHARMA LTD leads in volume — how do 25 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian diazepam exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Diazepam report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial diazepam trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian diazepam suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Diazepam India trade report
Product scope
Diazepam
All variants merged — branded and generic formulations of diazepam
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
71
Every commercial diazepam trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a mixed: Oct $468.9K, Nov $538.5K, Dec $93.9K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$468.9K
Oct USD
23 shipments
2
$538.5K
Nov USD
+14.8% MoM
3
$93.9K
Dec USD
-82.6% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov rose 14.8% in USD but shipment count kept steady.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $469K, making it the middle month by value.
Fig 3.2 Q4 cumulative USD reached $1.1M.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $70K rise in Nov, $445K decline in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Trade grew steadily across the quarter.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $469K | 23 shipments |
| Nov | $538K | 22 shipments |
| Dec | $94K | 26 shipments |
| Q4 Total | $1.1M | 71 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: United States held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: NEON LABORATORIES LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import diazepam from India, how much they buy, and who supplies each market
KEY TAKEAWAY
United States absorbs 32.2% of India’s 2025-Q4 diazepam trade ($355.1K). Beyond the top 10 destinations, 27 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Africa has 16 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 27 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much diazepam India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$41K
3.7% of trade
6 countries · 10 shipments
Europe
$320K
29.1% of trade
1 countries · 5 shipments
Americas
$366K
33.3% of trade
3 countries · 13 shipments
Africa
$374K
33.9% of trade
16 countries · 42 shipments
Oceania
$19
0.0% of trade
1 countries · 1 shipments
Fig 4.1 United States is the #1 corridor ($355K) — 27 flow arcs from India radiate across 5 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian diazepam it receives (light = low, dark = high). Orange arcs radiate from India to the top 27 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | United States | $355K | 11 | ALEMBIC PHARMACEUTICALS LTD | $255K | MYLAN LABORATORIES LTD | $100K | APOTHECON PHARMACEUTICALS PVT LTD | $868 |
| 2 | France | $320K | 5 | AJANTA PHARMA LTD | $320K | — | — | — | — |
| 3 | DR Congo | $126K | 7 | STANMARC ENTERPRISE | $40K | PHARMAX INDIA PVT LTD | $35K | AURA PHARMACEUTICALS PVT LTD | $32K |
| 4 | Sudan | $71K | 2 | NEON LABORATORIES LTD | $71K | — | — | — | — |
| 5 | Nigeria | $33K | 3 | LABORATE PHARMACEUTICALS INDIA LTD | $32K | ALPA LABORATORIES LTD | $712 | — | — |
| 6 | Rwanda | $22K | 3 | KILITCH DRUGS (INDIA) LTD | $22K | — | — | — | — |
| 7 | Ethiopia | $21K | 6 | KILITCH DRUGS (INDIA) LTD | $21K | — | — | — | — |
| 8 | Burkina Faso | $16K | 1 | SWISS PARENTERALS LTD | $16K | — | — | — | — |
| 9 | Madagascar | $16K | 1 | NANDANI MEDICAL LABORATORIES PVT LTD | $16K | — | — | — | — |
| 10 | Jordan | $16K | 3 | SWISS PARENTERALS LTD | $11K | NEON LABORATORIES LTD | $5K | — | — |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 3.7% of USD — but United States is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
32.2%
#1 country share
United States alone
82.2%
Top 5 share
5 of 27 countries
95.7%
Top 15 share
Long tail of 12 countries = 4.3%
HHI 2088
Destination HHI
Moderately concentrated
27
Countries served
Global pharma reach from India
16
Africa countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
25 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
AJANTA PHARMA LTD ($320.3K, 29.1% share) and ALEMBIC PHARMACEUTICALS LTD ($254.5K) together control 52.2% of India’s 2025-Q4 diazepam trade. The top 5 suppliers hold 72.3%. 25 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian diazepam suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 AJANTA PHARMA LTD leads by $66K over ALEMBIC PHARMACEUTICALS LTD — top 20 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: CIRON DRUGS AND is #12 by value but #2 by volume.
Fig 5.2 KILITCH DRUGS (INDIA) LTD also leads by shipment count (9) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: CIRON DRUGS AND moves from #2 by volume to #12 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 25 diazepam suppliers split into strategic segments
KEY TAKEAWAY
7 suppliers (25%) generate 79.7% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 AJANTA PHARMA LTD and ALEMBIC PHARMACEUTICALS LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 79.7% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | KILITCH DRUGS (INDIA) LTD | 4 | 2 | $43K |
| 2 | VENOR PHARMA LTD | 2 | 2 | $24K |
| 3 | CIRON DRUGS AND PHARMACEUTICALS PVT LTD | 2 | 3 | $21K |
| 4 | AJANTA PHARMA LTD | 1 | 1 | $320K |
| 5 | ALEMBIC PHARMACEUTICALS LTD | 1 | 1 | $255K |
| 6 | MYLAN LABORATORIES LTD | 1 | 1 | $100K |
| 7 | NEON LABORATORIES LTD | 1 | 4 | $78K |
| 8 | SWISS PARENTERALS LTD | 1 | 4 | $42K |
| 9 | STANMARC ENTERPRISE | 1 | 1 | $40K |
| 10 | PHARMAX INDIA PVT LTD | 1 | 1 | $35K |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the diazepam manufacturing hubs
KEY TAKEAWAY
Mumbai and Gujarat together account for $681K of India’s 2025-Q4 diazepam trade.
Fig 5.5 Mumbai (5 exporters, $427K) and Gujarat (1 exporters, $255K) are India’s diazepam capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
72.3%
Top 5 share
5 of 25 suppliers
88.7%
Top 10 share
10 of 25 suppliers
79.7%
Top 25% share
7 suppliers = 80% USD
HHI 1598
Supplier HHI
Moderate
25
Total suppliers
shipped Diazepam in 2025-Q4
20+ cities
Indian hubs
Mumbai and Gujarat lead
§5.2 Coming next: 4 exporter deep-dive profiles
Each of the top 4 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | NEON LABORATORIES LTD | $78K |
| #2 | KILITCH DRUGS (INDIA) LTD | $43K |
| #3 | VENOR PHARMA LTD | $24K |
| #4 | CIRON DRUGS AND PHARMACEUTICALS PVT LTD | $21K |
#4
EXPORTER PROFILE #1 OF 4
NEON LABORATORIES LTD
Andheri [E] · India’s #4 diazepam supplier by USD · 2025-Q4
2025-Q4 USD
$78K
7.1% market share
SHIPMENTS
6
avg $13K/ship
COUNTRIES
4
destination markets
BUYERS
4
4 single-sourced
BRANDED
33%
of shipments
DOSAGE FORMS
1
product types
TOP 4 DESTINATIONS
Sudan is the #1 market at $71K (90% of trade), followed by Jordan at $5K. 4 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Sudan | $71K | 2 | 90.4% |
| 2 | Jordan | $5K | 2 | 5.8% |
| 3 | Nepal | $3K | 1 | 3.8% |
| 4 | Papua New Guinea | $19 | 1 | 0.0% |
MONTHLY TREND
Oct peaked at $71K. Nov was the weakest at $0.
PRODUCT MIX
Injection dominates at 100% of trade.
TOP BUYERS · 4/4 LOCKED IN
4 of 4 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| ALABASS UNITED CO LTD | Sudan | $71K | ⚠ Locked |
| JORDAN ISLAMIC BANK | Jordan | $5K | ⚠ Locked |
| YETICHEM DISTRIBUTORS … | Nepal | $3K | ⚠ Locked |
| CITY PHARMACY LTD | Papua New Guinea | $19 | ⚠ Locked |
#4
EXPORTER PROFILE #1 OF 4 — TRADE FLOW MAP
NEON LABORATORIES LTD — Supplier → Country → Importer
4 destination countries, top 5 importers per country
Fig 5.P1.3 Sudan absorbs $71K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 4 destinations and up to 1 importers per destination.
#5
EXPORTER PROFILE #2 OF 4
KILITCH DRUGS (INDIA) LTD
Mumbai · India’s #5 diazepam supplier by USD · 2025-Q4
2025-Q4 USD
$43K
3.9% market share
SHIPMENTS
9
avg $5K/ship
COUNTRIES
2
destination markets
BUYERS
2
1 single-sourced
BRANDED
44%
of shipments
DOSAGE FORMS
4
product types
TOP 2 DESTINATIONS
Rwanda is the #1 market at $22K (52% of trade), followed by Ethiopia at $21K. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Rwanda | $22K | 3 | 51.9% |
| 2 | Ethiopia | $21K | 6 | 48.1% |
MONTHLY TREND
Nov peaked at $43K. Oct was the weakest at $0.
PRODUCT MIX
Injection dominates at 100% of trade. control (0.0%) and standard are secondary formulations.
TOP BUYERS · 1/1 LOCKED IN
1 of 1 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| Undisclosed buyer | Rwanda | $43K | N/A |
| ESTRO IMPORT AND EXPOR… | Ethiopia | $2 | ⚠ Locked |
#5
EXPORTER PROFILE #2 OF 4 — TRADE FLOW MAP
KILITCH DRUGS (INDIA) LTD — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P2.3 Rwanda absorbs $22K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 2 importers per destination.
#11
EXPORTER PROFILE #3 OF 4
VENOR PHARMA LTD
New Delhi · India’s #11 diazepam supplier by USD · 2025-Q4
2025-Q4 USD
$24K
2.2% market share
SHIPMENTS
5
avg $5K/ship
COUNTRIES
2
destination markets
BUYERS
3
2 single-sourced
BRANDED
80%
of shipments
DOSAGE FORMS
2
product types
TOP 2 DESTINATIONS
DR Congo is the #1 market at $18K (76% of trade), followed by Malawi at $6K. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | DR Congo | $18K | 4 | 76.5% |
| 2 | Malawi | $6K | 1 | 23.5% |
MONTHLY TREND
Oct peaked at $18K. Dec was the weakest at $225.
PRODUCT MIX
Tablet dominates at 76% of trade. Injection (23.5%) and others are secondary formulations.
TOP BUYERS · 2/2 LOCKED IN
2 of 2 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| UNIQUE PHARMAAV. BAKON… | DR Congo | $18K | ⚠ Locked |
| Undisclosed buyer | Malawi | $6K | N/A |
| PRINCE PHARMA | DR Congo | $225 | ⚠ Locked |
#11
EXPORTER PROFILE #3 OF 4 — TRADE FLOW MAP
VENOR PHARMA LTD — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P3.3 DR Congo absorbs $18K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 2 importers per destination.
#12
EXPORTER PROFILE #4 OF 4
CIRON DRUGS AND PHARMACEUTICALS PVT LTD
Palghar · India’s #12 diazepam supplier by USD · 2025-Q4
2025-Q4 USD
$21K
1.9% market share
SHIPMENTS
9
avg $2K/ship
COUNTRIES
3
destination markets
BUYERS
5
4 single-sourced
BRANDED
44%
of shipments
DOSAGE FORMS
2
product types
TOP 3 DESTINATIONS
Kenya is the #1 market at $13K (63% of trade), followed by Timor-Leste at $8K. 3 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Kenya | $13K | 5 | 63.2% |
| 2 | Timor-Leste | $8K | 3 | 35.8% |
| 3 | Dominican Republic | $221 | 1 | 1.0% |
MONTHLY TREND
Nov peaked at $21K. Oct was the weakest at $0.
PRODUCT MIX
Injection dominates at 87% of trade. Ampoule (12.9%) and others are secondary formulations.
TOP BUYERS · 4/4 LOCKED IN
4 of 4 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| Undisclosed buyer | Timor-Leste | $9K | N/A |
| DAWA LTD | Kenya | $6K | ⚠ Locked |
| INSTITUTO NACIONAL DE … | Timor-Leste | $5K | ⚠ Locked |
| RENE PHARMACY LTD | Kenya | $493 | ⚠ Locked |
| MAXBIO PHARMA SRL | Dominican Republic | $221 | ⚠ Locked |
#12
EXPORTER PROFILE #4 OF 4 — TRADE FLOW MAP
CIRON DRUGS AND PHARMACEUTICALS PVT LTD — Supplier → Country → Importer
3 destination countries, top 5 importers per country
Fig 5.P4.3 Kenya absorbs $13K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 3 destinations and up to 3 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
35 importers across 27 countries — who is buying Indian diazepam and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 25 importers together hold only 90.7% of total USD. 94% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian diazepam. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 PLANET PHARMA SA is the #1 importer at $320K (29.1%) — top 25 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 25 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
94%
Single-source
33 buyers rely on exactly 1 Indian supplier
3%
Dual-source
1 buyers use 2 Indian suppliers
3%
Multi-source (3–4)
1 buyers diversified across 3–4
0%
Broad-source (5+)
0 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source diazepam from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
DR Congo 5 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| CAISA PHARMA INTERNATI… | STANMARC ENTERPRISE | $40K | $4.991 | Injection |
| UNIQUE PHARMASTE UNION… | PHARMAX INDIA PVT LTD | $35K | $0.044 | Solution |
| NEW CESAMEX SARL | AURA PHARMACEUTICALS… | $32K | $5.351 | Injection |
| UNIQUE PHARMAAV. BAKON… | VENOR PHARMA LTD | $18K | $0.0036 | Tablet |
| PRINCE PHARMA | VENOR PHARMA LTD | $224.723 | $0.0000 | Tablet |
United States 4 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| J. KNIPPER & COMPANY | ALEMBIC PHARMACEUTIC… | $255K | $5.796 | Injection |
| MYLAN PHARMACEUTICALS … | MYLAN LABORATORIES LTD | $100K | $0.0082 | Tablet |
| EVERSANA LIFE SCIENCE … | APOTHECON PHARMACEUT… | $868.087 | $0.051 | Gel |
| DR REDDYS LABORATORIES… | DRREDDYS LABORATORIE… | $224.600 | $0.028 | Injection |
Jordan 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| AL-LILIUM DRUG STORE | SWISS PARENTERALS LTD | $11K | $2.244 | Injection |
| JORDAN ISLAMIC BANK | NEON LABORATORIES LTD | $5K | $1.100 | Injection |
Kenya 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| DAWA LTD | CIRON DRUGS AND PHAR… | $6K | $0.130 | Injection |
| RENE PHARMACY LTD | CIRON DRUGS AND PHAR… | $492.597 | $0.0008 | Injection |
Ghana 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| VESTER PHARMACEUTICALS… | SHUKRA PHARMACEUTICA… | $0.594 | $0.099 | Injection |
| SUCCESS PHARMACEUTICAL… | SHUKRA PHARMACEUTICA… | $0.594 | $0.099 | Injection |
§6.3 Price positioning — top 25 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | PLANET PHARMA SA | France | $320K | $64K | Premium |
| 2 | J. KNIPPER & COMPANY | United States | $255K | $127K | Premium |
| 3 | MYLAN PHARMACEUTICAL… | United States | $100K | $17K | Mid |
| 4 | ALABASS UNITED CO LTD | Sudan | $71K | $35K | Premium |
| 5 | CAISA PHARMA INTERNA… | DR Congo | $40K | $40K | Premium |
| 6 | UNIQUE PHARMASTE UNI… | DR Congo | $35K | $35K | Premium |
| 7 | NEW CESAMEX SARL | DR Congo | $32K | $32K | Mid |
| 8 | UNIQUE PHARMAAV. BAK… | DR Congo | $18K | $6K | Budget |
| 9 | CENTRALE DACHAT DES … | Burkina Faso | $16K | $16K | Mid |
| 10 | SALAMA CENTRALE D AC… | Madagascar | $16K | $16K | Mid |
| 11 | AFRICHAHEL FARMACIA … | Angola | $12K | $3K | Budget |
| 12 | GITTOES PHARMACEUTIC… | Uganda | $12K | $12K | Budget |
| 13 | AL-LILIUM DRUG STORE | Jordan | $11K | $11K | Budget |
| 14 | GENERICS AND SPECIAL… | Mozambique | $9K | $5K | Budget |
| 15 | IMMENSE CORP GROUP C… | Cambodia | $9K | $9K | Budget |
| 16 | CENTRALE DACHAT DE M… | Mauritania | $9K | $9K | Budget |
| 17 | DAWA LTD | Kenya | $6K | $6K | Budget |
| 18 | ARTEMIS PHARMACEUTIC… | South Africa | $6K | $6K | Budget |
| 19 | NEBULA TRADING CO LTD | Myanmar | $6K | $6K | Budget |
| 20 | INSTITUTO NACIONAL D… | Timor-Leste | $5K | $3K | Budget |
| 21 | JORDAN ISLAMIC BANK | Jordan | $5K | $2K | Budget |
| 22 | YETICHEM DISTRIBUTOR… | Nepal | $3K | $3K | Budget |
| 23 | LOTUS PHARMA | Burundi | $1K | $717.000 | Budget |
| 24 | EVERSANA LIFE SCIENC… | United States | $868.087 | $434.000 | Budget |
| 25 | RENE PHARMACY LTD | Kenya | $492.597 | $164.000 | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 AJANTA PHARMA LTD → PLANET PHARMA SA is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian diazepam prices vary by supplier, country and dosage form
KEY TAKEAWAY
Diazepam prices span 4333325× ($0.0000 → $177.68). The coefficient of variation is 3.62. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.0000 | Lowest observed unit price |
| P5 | $0.0008 | 5th percentile |
| P25 | $0.011 | 25th percentile (Q1) |
| Median | $0.125 | 50th percentile (Q2) |
| P75 | $1.77 | 75th percentile (Q3) |
| P95 | $37.61 | 95th percentile |
| Max | $177.68 | Highest observed unit price |
| Mean | $7.37 | Arithmetic average |
| CV | 362% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 NEM LABORATORIES PVT LTD prices at $148.06/unit vs market median $0.125.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. MYLAN LABORATORIES LTD Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. AJANTA PHARMA LTD Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. PHARMAX INDIA PVT Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. STANMARC ENTERPRISE Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Oct 2025 | NEM LABORATORIES… | Mozambique | Injection | 50 | $9K | $177.68 | Sterile formulation premium |
| Oct 2025 | NEM LABORATORIES… | Mozambique | Injection | 1 | $118.45 | $118.45 | Sterile formulation premium |
| Nov 2025 | SYNCOM FORMULATI… | Burundi | Tablet | 23 | $1K | $59.93 | Specialty / small-batch |
| Nov 2025 | SYNCOM FORMULATI… | Burundi | Tablet | 1 | $55.14 | $55.14 | Specialty / small-batch |
| Nov 2025 | AJANTA PHARMA LTD | France | Tablet | 219 | $2K | $11.32 | Specialty / small-batch |
| Nov 2025 | AJANTA PHARMA LTD | France | Tablet | 15K | $149K | $9.68 | Specialty / small-batch |
| Nov 2025 | PSYCHOTROPICS IN… | Cambodia | Injection | 1K | $9K | $8.98 | Sterile formulation premium |
| Nov 2025 | AJANTA PHARMA LTD | France | Tablet | 8K | $63K | $7.83 | Specialty / small-batch |
| Nov 2025 | ALEMBIC PHARMACE… | United States | Injection | 22K | $128K | $5.86 | Sterile formulation premium |
| Nov 2025 | AJANTA PHARMA LTD | France | Tablet | 13K | $74K | $5.81 | Specialty / small-batch |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | KILITCH DRUGS (I… | Ethiopia | Injection | 89K | $253.42 | $0.0028 | Sterile formulation premium |
| Dec 2025 | CIRON DRUGS AND … | Dominican Republic | Injection | 70K | $220.96 | $0.0032 | Sterile formulation premium |
| Oct 2025 | VENOR PHARMA LTD | DR Congo | Tablet | 2.7M | $10K | $0.0036 | Bulk generic tablet |
| Oct 2025 | VENOR PHARMA LTD | DR Congo | Tablet | 2.2M | $8K | $0.0036 | Bulk generic tablet |
| Oct 2025 | VENOR PHARMA LTD | DR Congo | Tablet | 77K | $276.93 | $0.0036 | Bulk generic tablet |
| Oct 2025 | MYLAN LABORATORI… | United States | Tablet | 576K | $4K | $0.0062 | Bulk generic tablet |
| Oct 2025 | MYLAN LABORATORI… | United States | Tablet | 5.1M | $37K | $0.0073 | Bulk generic tablet |
| Oct 2025 | MYLAN LABORATORI… | United States | Tablet | 1.9M | $15K | $0.0078 | Bulk generic tablet |
| Oct 2025 | MYLAN LABORATORI… | United States | Tablet | 2.7M | $24K | $0.0089 | Bulk generic tablet |
| Oct 2025 | MYLAN LABORATORI… | United States | Tablet | 414K | $4K | $0.0094 | Bulk generic tablet |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship diazepam, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Diazepam leaves India through 8+ ports. The top 5 (NHAVA SHEVA SEA (JNPT), MUMBAI AIR (SAHAR), AHMEDABAD AIR) handle 96.1% of total USD. AIR moves 42% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 NHAVA SHEVA SEA (JNPT) handles $383K — top 8 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 PARIS is the #1 global destination port — top 25 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
AIR dominates at 42% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
AIR
$521K
47.3% of USD · 42.3% of ships
SEA
$511K
46.4% of USD · 52.1% of ships
ICD
$70K
6.4% of USD · 5.6% of ships
Fig 8.3 The dominant corridor is MUMBAI AIR (SAHAR) → Air → Europe ($320K).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
Ethiopia is the most concentrated destination (HHI 10000, 1 suppliers). DR Congo is the most competitive (HHI 2665).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Ethiopia (HHI 10,000) is the most concentrated — DR Congo (HHI 2,665) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| PLANET PHARMA SA | France | AJANTA PHARMA LTD | $320K | 5 | HIGH |
| J. KNIPPER & COMPANY | United States | ALEMBIC PHARMACE… | $255K | 2 | HIGH |
| MYLAN PHARMACEUTICAL… | United States | MYLAN LABORATORI… | $100K | 6 | MEDIUM |
| ALABASS UNITED CO LTD | Sudan | NEON LABORATORIE… | $71K | 2 | MEDIUM |
| CAISA PHARMA INTERNA… | DR Congo | STANMARC ENTERPR… | $40K | 1 | MEDIUM |
| UNIQUE PHARMASTE UNI… | DR Congo | PHARMAX INDIA PV… | $35K | 1 | MEDIUM |
| NEW CESAMEX SARL | DR Congo | AURA PHARMACEUTI… | $32K | 1 | MEDIUM |
| UNIQUE PHARMAAV. BAK… | DR Congo | VENOR PHARMA LTD | $18K | 3 | MEDIUM |
Conclusion: 33 buyers depend on exactly one Indian supplier, representing $1000K in trade. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| United States | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| France | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| DR Congo | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Sudan | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Nigeria | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Rwanda | Tier 3 (emerging) | 14–28 days (sea) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Ethiopia | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Burkina Faso | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Madagascar | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Jordan | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Kenya | Tier 3 (emerging) | 14–28 days (sea) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Angola | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Uganda | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Venezuela | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Mozambique | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 15 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in France | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit Ethiopia lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter United States (4 suppliers) | This Q | HIGH |
| A6 | Enter France (1 suppliers) | This Q | MED |
| A8 | Build France distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (SWISS PARENTERALS) | This Q | MED |
| A7 | Register for United States tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | United States | Other | 4 | $355K | -99.5% | LOW | Low competition (4 suppliers), accessible market |
| 2 | France | Other | 1 | $320K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | DR Congo | Africa | 4 | $126K | -99.8% | LOW | Low competition (4 suppliers), accessible market |
| 4 | Sudan | Africa | 1 | $71K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | Nigeria | Africa | 2 | $33K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 6 | Rwanda | Africa | 1 | $22K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | Ethiopia | Africa | 1 | $21K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 8 | Burkina Faso | Africa | 1 | $16K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 9 | Madagascar | Africa | 1 | $16K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 10 | Jordan | Other | 2 | $16K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 11 | Kenya | Africa | 1 | $13K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 12 | Angola | Africa | 1 | $12K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 13 | Uganda | Africa | 1 | $12K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | Venezuela | Other | 1 | $11K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Mozambique | Africa | 1 | $9K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 71 2025-Q4 Diazepam shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/diazepam
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 71 2025-Q4 diazepam shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian diazepam shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
71
across all regions
TOTAL USD
$1.10M
2025-Q4 FOB value
UNITS
27.9M
tablets, capsules, etc.
SUPPLIERS
25
Indian exporters
BUYERS
35
global importers
COUNTRIES
27
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $374K (33.9%), spanning 16 countries.
25 Indian suppliers shipped to 35 buyers across 27 countries — average shipment value $16K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
16 countries · 42 shipments · $374K · 17 Indian suppliers · 21 buyers
SHIPMENTS
42
USD
$374K
COUNTRIES
16
SUPPLIERS
17
BUYERS
21
HHI
991
competitive
Top 16 destination countries in Africa
1
DR Congo (33.6%)
$126K
2
Sudan (18.9%)
$71K
3
Nigeria (8.8%)
$33K
4
Rwanda (6.0%)
$22K
5
Ethiopia (5.5%)
$21K
6
Burkina Faso (4.3%)
$16K
7
Madagascar (4.3%)
$16K
8
Kenya (3.6%)
$13K
9
Angola (3.3%)
$12K
10
Uganda (3.3%)
$12K
11
Mozambique (2.4%)
$9K
12
Mauritania (2.4%)
$9K
13
South Africa (1.6%)
$6K
14
Malawi (1.5%)
$6K
15
Burundi (0.4%)
$1K
16
Ghana (0.0%)
$1.19
Top 17 Indian suppliers into Africa
1
NEON LABORATORIES LTD
$71K
2
KILITCH DRUGS (INDIA) LTD
$43K
3
STANMARC ENTERPRISE
$40K
4
PHARMAX INDIA PVT LTD
$35K
5
LABORATE PHARMACEUTICALS INDIA LTD
$32K
6
AURA PHARMACEUTICALS PVT LTD
$32K
7
SWISS PARENTERALS LTD
$25K
8
VENOR PHARMA LTD
$24K
9
NANDANI MEDICAL LABORATORIES PVT LTD
$16K
10
CIRON DRUGS AND PHARMACEUTICALS PVT LTD
$13K
11
REKVINA PHARMACEUTICALS
$12K
12
CENTAUR PHARMACEUTICALS PVT LTD
$12K
13
NEM LABORATORIES PVT LTD
$9K
14
HUMANIQE BIOPHARMACEUTICALS PVT LTD
$6K
15
SYNCOM FORMULATIONS (INDIA) LTD
$1K
16
ALPA LABORATORIES LTD
$711.76
17
SHUKRA PHARMACEUTICALS LTD
$1.19
Top 19 Africa importers
1
ALABASS UNITED CO LTD · Sudan
$71K
2
CAISA PHARMA INTERNATIONALAV. BAKON · DR Congo
$40K
3
UNIQUE PHARMASTE UNION DE QUERIR · DR Congo
$35K
4
NEW CESAMEX SARL · DR Congo
$32K
5
UNIQUE PHARMAAV. BAKONGO NO · DR Congo
$18K
6
CENTRALE DACHAT DES MEDICAMENTS · Burkina Faso
$16K
7
SALAMA CENTRALE D ACHATS DE · Madagascar
$16K
8
AFRICHAHEL FARMACIA (SU) LDA,LOJA · Angola
$12K
9
GITTOES PHARMACEUTICALS LTD · Uganda
$12K
10
GENERICS AND SPECIALITIES LDAVALE D · Mozambique
$9K
11
CENTRALE DACHAT DE MEDICAMENTS ESS · Mauritania
$9K
12
DAWA LTD · Kenya
$6K
13
ARTEMIS PHARMACEUTICALS PTY LTD · South Africa
$6K
14
LOTUS PHARMA · Burundi
$1K
15
RENE PHARMACY LTD · Kenya
$492.60
16
PRINCE PHARMA · DR Congo
$224.72
17
ESTRO IMPORT AND EXPORT PVT LTD · Ethiopia
$2.06
18
VESTER PHARMACEUTICALS LTD · Ghana
$0.594
19
SUCCESS PHARMACEUTICALS LTD · Ghana
$0.594
Top 5 dosage forms
1
Injection
$294K
2
Tablet
$44K
3
Solution
$35K
4
control
$1.02
5
standard
$1.02
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 16 | $243K | $15K |
| Nov | 11 | $63K | $6K |
| Dec | 15 | $68K | $5K |
Shipment register · 42 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — NEON LABORATORIES LTD · 2 shipments · $71K | |||||||||||
| 1 | Oct 2025 | ALABASS UNITED CO LTD | Sudan | Injection | 20.0K | NOS | $1.77 | $35K | NHAVA SHEVA SEA (JNPT) | Port Sudan | SEA |
| 2 | Oct 2025 | ALABASS UNITED CO LTD | Sudan | Injection | 20.0K | NOS | $1.77 | $35K | NHAVA SHEVA SEA (JNPT) | Port Sudan | SEA |
| SUPPLIER #2 — KILITCH DRUGS (INDIA) LTD · 9 shipments · $43K | |||||||||||
| 3 | Nov 2025 | UNLISTED BUYER | Rwanda | Injection | 89.5K | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Dar Es Salaam | SEA |
| 4 | Nov 2025 | UNLISTED BUYER | Ethiopia | Injection | 89.0K | NOS | $0.230 | $20K | MUMBAI AIR (SAHAR) | ADDIS ABABA | AIR |
| 5 | Nov 2025 | UNLISTED BUYER | Rwanda | Injection | 89.5K | VLS | $0.125 | $11K | NHAVA SHEVA SEA (JNPT) | Dar Es Salaam | SEA |
| 6 | Nov 2025 | UNLISTED BUYER | Rwanda | Injection | 89.5K | NOS | $0.125 | $11K | NHAVA SHEVA SEA (JNPT) | Dar Es Salaam | SEA |
| 7 | Dec 2025 | ESTRO IMPORT AND EXPORT PVT LTD | Ethiopia | control | 1 | NOS | $1.02 | $1.02 | MUMBAI AIR (SAHAR) | ADDIS ABABA | AIR |
| 8 | Dec 2025 | ESTRO IMPORT AND EXPORT PVT LTD | Ethiopia | standard | 1 | NOS | $1.02 | $1.02 | MUMBAI AIR (SAHAR) | ADDIS ABABA | AIR |
| 9 | Dec 2025 | UNLISTED BUYER | Ethiopia | Injection | 89.0K | NOS | $0.0028 | $253.42 | MUMBAI AIR (SAHAR) | ADDIS ABABA | AIR |
| 10 | Dec 2025 | ESTRO IMPORT AND EXPORT PVT LTD | Ethiopia | Tablet | 1 | NOS | $0.011 | $0.011 | MUMBAI AIR (SAHAR) | ADDIS ABABA | AIR |
| 11 | Dec 2025 | ESTRO IMPORT AND EXPORT PVT LTD | Ethiopia | Tablet | 1 | NOS | $0.011 | $0.011 | MUMBAI AIR (SAHAR) | ADDIS ABABA | AIR |
| SUPPLIER #3 — STANMARC ENTERPRISE · 1 shipments · $40K | |||||||||||
| 12 | Oct 2025 | CAISA PHARMA INTERNATIONALAV. BAKON | DR Congo | Injection | 8.0K | NOS | $4.99 | $40K | NHAVA SHEVA SEA (JNPT) | Matadi | SEA |
| SUPPLIER #4 — PHARMAX INDIA PVT LTD · 1 shipments · $35K | |||||||||||
| 13 | Oct 2025 | UNIQUE PHARMASTE UNION DE QUERIR | DR Congo | Solution | 800.0K | NOS | $0.044 | $35K | NHAVA SHEVA SEA (JNPT) | Matadi | SEA |
| SUPPLIER #5 — LABORATE PHARMACEUTICALS INDIA LTD · 1 shipments · $32K | |||||||||||
| 14 | Dec 2025 | UNLISTED BUYER | Nigeria | Injection | 6.0K | NOS | $5.37 | $32K | PATLI ICD | APAPA | ICD |
| SUPPLIER #6 — AURA PHARMACEUTICALS PVT LTD · 1 shipments · $32K | |||||||||||
| 15 | Oct 2025 | NEW CESAMEX SARL | DR Congo | Injection | 6.0K | NOS | $5.35 | $32K | NHAVA SHEVA SEA (JNPT) | Matadi | SEA |
| SUPPLIER #7 — SWISS PARENTERALS LTD · 2 shipments · $25K | |||||||||||
| 16 | Oct 2025 | CENTRALE DACHAT DE MEDICAMENTS ESS | Mauritania | Injection | 6.0K | NOS | $1.50 | $9K | AHMEDABAD AIR | NOUAKCHOTT | AIR |
| 17 | Dec 2025 | CENTRALE DACHAT DES MEDICAMENTS | Burkina Faso | Injection | 152.0K | NOS | $0.106 | $16K | AHMEDABAD ICD | OUAGADOUGOU | ICD |
| SUPPLIER #8 — VENOR PHARMA LTD · 5 shipments · $24K | |||||||||||
| 18 | Oct 2025 | UNIQUE PHARMAAV. BAKONGO NO | DR Congo | Tablet | 2.7M | NOS | $0.0036 | $10K | NHAVA SHEVA SEA (JNPT) | Kinshasa | SEA |
| 19 | Oct 2025 | UNIQUE PHARMAAV. BAKONGO NO | DR Congo | Tablet | 2.2M | NOS | $0.0036 | $8K | NHAVA SHEVA SEA (JNPT) | Kinshasa | SEA |
| 20 | Oct 2025 | UNIQUE PHARMAAV. BAKONGO NO | DR Congo | Tablet | 76.8K | NOS | $0.0036 | $276.93 | NHAVA SHEVA SEA (JNPT) | Kinshasa | SEA |
| 21 | Nov 2025 | UNLISTED BUYER | Malawi | Injection | 30.0K | NOS | $0.187 | $6K | DELHI AIR | LILONGWE | AIR |
| 22 | Dec 2025 | PRINCE PHARMA | DR Congo | Tablet | 5.5M | NOS | $0.0000 | $224.72 | NHAVA SHEVA SEA (JNPT) | Matadi | SEA |
| SUPPLIER #9 — NANDANI MEDICAL LABORATORIES PVT LTD · 1 shipments · $16K | |||||||||||
| 23 | Oct 2025 | SALAMA CENTRALE D ACHATS DE | Madagascar | Injection | 148.1K | NOS | $0.109 | $16K | DHANNAD ICD | Toamasina | ICD |
| SUPPLIER #10 — CIRON DRUGS AND PHARMACEUTICALS PVT LTD · 5 shipments · $13K | |||||||||||
| 24 | Nov 2025 | DAWA LTD | Kenya | Injection | 50.0K | NOS | $0.130 | $6K | NHAVA SHEVA SEA (JNPT) | Mombasa | SEA |
| 25 | Nov 2025 | UNKNOWN BUYER | Kenya | Injection | 50.0K | NOS | $0.130 | $6K | NHAVA SHEVA SEA (JNPT) | Mombasa | SEA |
| 26 | Dec 2025 | RENE PHARMACY LTD | Kenya | Injection | 450.0K | NOS | $0.0008 | $341.03 | NHAVA SHEVA SEA (JNPT) | Mombasa | SEA |
| 27 | Dec 2025 | RENE PHARMACY LTD | Kenya | Injection | 0 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Mombasa | SEA |
| 28 | Dec 2025 | RENE PHARMACY LTD | Kenya | Injection | 200.0K | NOS | $0.0008 | $151.57 | NHAVA SHEVA SEA (JNPT) | Mombasa | SEA |
| SUPPLIER #11 — REKVINA PHARMACEUTICALS · 4 shipments · $12K | |||||||||||
| 29 | Oct 2025 | AFRICHAHEL FARMACIA (SU) LDA,LOJA | Angola | Tablet | 30.0K | NOS | $0.099 | $3K | NHAVA SHEVA SEA (JNPT) | Luanda | SEA |
| 30 | Oct 2025 | AFRICHAHEL FARMACIA (SU) LDA,LOJA | Angola | Tablet | 30.0K | NOS | $0.109 | $3K | NHAVA SHEVA SEA (JNPT) | Luanda | SEA |
| 31 | Oct 2025 | AFRICHAHEL FARMACIA (SU) LDA,LOJA | Angola | Tablet | 30.0K | NOS | $0.099 | $3K | NHAVA SHEVA SEA (JNPT) | Luanda | SEA |
| 32 | Oct 2025 | AFRICHAHEL FARMACIA (SU) LDA,LOJA | Angola | Tablet | 30.0K | NOS | $0.109 | $3K | NHAVA SHEVA SEA (JNPT) | Luanda | SEA |
| SUPPLIER #12 — CENTAUR PHARMACEUTICALS PVT LTD · 1 shipments · $12K | |||||||||||
| 33 | Dec 2025 | GITTOES PHARMACEUTICALS LTD | Uganda | Tablet | 2.7K | NOS | $4.52 | $12K | NHAVA SHEVA SEA (JNPT) | Mombasa | SEA |
| SUPPLIER #13 — NEM LABORATORIES PVT LTD · 2 shipments · $9K | |||||||||||
| 34 | Oct 2025 | GENERICS AND SPECIALITIES LDAVALE D | Mozambique | Injection | 50 | NOS | $177.68 | $9K | NHAVA SHEVA SEA (JNPT) | Maputo | SEA |
| 35 | Oct 2025 | GENERICS AND SPECIALITIES LDAVALE D | Mozambique | Injection | 1 | NOS | $118.45 | $118.45 | NHAVA SHEVA SEA (JNPT) | Maputo | SEA |
| SUPPLIER #14 — HUMANIQE BIOPHARMACEUTICALS PVT LTD · 1 shipments · $6K | |||||||||||
| 36 | Dec 2025 | ARTEMIS PHARMACEUTICALS PTY LTD | South Africa | Injection | 5.1K | NOS | $1.16 | $6K | AHMEDABAD AIR | JOHANNESBURG - JOHAN | AIR |
| SUPPLIER #15 — SYNCOM FORMULATIONS (INDIA) LTD · 2 shipments · $1K | |||||||||||
| 37 | Nov 2025 | LOTUS PHARMA | Burundi | Tablet | 23 | NOS | $59.93 | $1K | MUMBAI AIR (SAHAR) | BUJUMBURA | AIR |
| 38 | Nov 2025 | LOTUS PHARMA | Burundi | Tablet | 1 | NOS | $55.14 | $55.14 | MUMBAI AIR (SAHAR) | BUJUMBURA | AIR |
| SUPPLIER #16 — ALPA LABORATORIES LTD · 2 shipments · $711.76 | |||||||||||
| 39 | Dec 2025 | UNLISTED BUYER | Nigeria | Injection | 1.9M | NOS | $0.0003 | $547.73 | NHAVA SHEVA SEA (JNPT) | Apapa | SEA |
| 40 | Dec 2025 | UNLISTED BUYER | Nigeria | Injection | 576.0K | NOS | $0.0003 | $164.03 | NHAVA SHEVA SEA (JNPT) | Apapa | AIR |
| SUPPLIER #17 — SHUKRA PHARMACEUTICALS LTD · 2 shipments · $1.19 | |||||||||||
| 41 | Nov 2025 | VESTER PHARMACEUTICALS LTD | Ghana | Injection | 6 | NOS | $0.099 | $0.594 | AHMEDABAD AIR | ACCRA | AIR |
| 42 | Nov 2025 | SUCCESS PHARMACEUTICALS LTD | Ghana | Injection | 6 | NOS | $0.099 | $0.594 | AHMEDABAD AIR | ACCRA | AIR |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
6 countries · 10 shipments · $41K · 5 Indian suppliers · 8 buyers
SHIPMENTS
10
USD
$41K
COUNTRIES
6
SUPPLIERS
5
BUYERS
8
HHI
2,853
concentrated
Top 6 destination countries in Asia
1
Jordan (38.6%)
$16K
2
Cambodia (21.9%)
$9K
3
Timor-Leste (18.6%)
$8K
4
Myanmar (13.7%)
$6K
5
Nepal (7.2%)
$3K
6
Singapore (0.0%)
$0.114
Top 5 Indian suppliers into Asia
1
SWISS PARENTERALS LTD
$17K
2
PSYCHOTROPICS INDIA LTD
$9K
3
CIRON DRUGS AND PHARMACEUTICALS PVT LTD
$8K
4
NEON LABORATORIES LTD
$8K
5
PSI CRO PHARMA INDIA PVT LTD
$0.114
Top 7 Asia importers
1
AL-LILIUM DRUG STORE · Jordan
$11K
2
IMMENSE CORP GROUP CO LTD · Cambodia
$9K
3
NEBULA TRADING CO LTD · Myanmar
$6K
4
INSTITUTO NACIONAL DE FARMACIA E · Timor-Leste
$5K
5
JORDAN ISLAMIC BANK · Jordan
$5K
6
YETICHEM DISTRIBUTORS PVT LTD · Nepal
$3K
7
LABCORP DEVELOPMENT (ASIA) PTE LTD · Singapore
$0.114
Top 2 dosage forms
1
Injection
$38K
2
Ampoule
$3K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 4 | $17K | $4K |
| Dec | 6 | $24K | $4K |
Shipment register · 10 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — SWISS PARENTERALS LTD · 2 shipments · $17K | |||||||||||
| 1 | Dec 2025 | NEBULA TRADING CO LTD | Myanmar | Injection | 5.0K | NOS | $1.12 | $6K | AHMEDABAD ICD | YANGON | ICD |
| 2 | Dec 2025 | AL-LILIUM DRUG STORE | Jordan | Injection | 5.0K | NOS | $2.24 | $11K | AHMEDABAD AIR | AMMAN | AIR |
| SUPPLIER #2 — PSYCHOTROPICS INDIA LTD · 1 shipments · $9K | |||||||||||
| 3 | Nov 2025 | IMMENSE CORP GROUP CO LTD | Cambodia | Injection | 1.0K | NOS | $8.98 | $9K | NHAVA SHEVA SEA (JNPT) | Sihanoukville (Kompo | SEA |
| SUPPLIER #3 — CIRON DRUGS AND PHARMACEUTICALS PVT LTD · 3 shipments · $8K | |||||||||||
| 4 | Nov 2025 | INSTITUTO NACIONAL DE FARMACIA E | Timor-Leste | Injection | 12.0K | NOS | $0.203 | $2K | NHAVA SHEVA SEA (JNPT) | Dili | SEA |
| 5 | Nov 2025 | UNKNOWN BUYER | Timor-Leste | Injection | 12.0K | NOS | $0.203 | $2K | NHAVA SHEVA SEA (JNPT) | Dili | SEA |
| 6 | Nov 2025 | INSTITUTO NACIONAL DE FARMACIA E | Timor-Leste | Ampoule | 12.0K | NOS | $0.228 | $3K | NHAVA SHEVA SEA (JNPT) | Dili | SEA |
| SUPPLIER #4 — NEON LABORATORIES LTD · 3 shipments · $8K | |||||||||||
| 7 | Dec 2025 | JORDAN ISLAMIC BANK | Jordan | Injection | 4.2K | NOS | $1.10 | $5K | MUMBAI AIR (SAHAR) | AMMAN | AIR |
| 8 | Dec 2025 | JORDAN ISLAMIC BANK | Jordan | Injection | 2 | NOS | $0.100 | $0.200 | MUMBAI AIR (SAHAR) | AMMAN | AIR |
| 9 | Dec 2025 | YETICHEM DISTRIBUTORS PVT LTD | Nepal | Injection | 6.0K | NOS | $0.492 | $3K | MUMBAI AIR (SAHAR) | KATHMANDU - TRIBHUVA | AIR |
| SUPPLIER #5 — PSI CRO PHARMA INDIA PVT LTD · 1 shipments · $0.114 | |||||||||||
| 10 | Dec 2025 | LABCORP DEVELOPMENT (ASIA) PTE LTD | Singapore | Injection | 10 | NOS | $0.011 | $0.114 | DELHI AIR | SINGAPORE | AIR |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
1 countries · 5 shipments · $320K · 1 Indian suppliers · 1 buyers
SHIPMENTS
5
USD
$320K
COUNTRIES
1
SUPPLIERS
1
BUYERS
1
HHI
10,000
concentrated
Top 1 destination countries in Europe
1
France (100.0%)
$320K
Top 1 Indian suppliers into Europe
1
AJANTA PHARMA LTD
$320K
Top 1 Europe importers
1
PLANET PHARMA SA · France
$320K
Top 1 dosage forms
1
Tablet
$320K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 5 | $320K | $64K |
| Dec | 0 | $0.0000 | — |
Shipment register · 5 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — AJANTA PHARMA LTD · 5 shipments · $320K | |||||||||||
| 1 | Nov 2025 | PLANET PHARMA SA | France | Tablet | 12.7K | NOS | $5.81 | $74K | MUMBAI AIR (SAHAR) | PARIS | AIR |
| 2 | Nov 2025 | PLANET PHARMA SA | France | Tablet | 15.4K | NOS | $9.68 | $149K | MUMBAI AIR (SAHAR) | PARIS | AIR |
| 3 | Nov 2025 | PLANET PHARMA SA | France | Tablet | 219 | NOS | $11.32 | $2K | MUMBAI AIR (SAHAR) | PARIS | AIR |
| 4 | Nov 2025 | PLANET PHARMA SA | France | Tablet | 6.8K | NOS | $4.70 | $32K | MUMBAI AIR (SAHAR) | PARIS | AIR |
| 5 | Nov 2025 | PLANET PHARMA SA | France | Tablet | 8.0K | NOS | $7.83 | $63K | MUMBAI AIR (SAHAR) | PARIS | AIR |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
3 countries · 13 shipments · $366K · 6 Indian suppliers · 6 buyers
SHIPMENTS
13
USD
$366K
COUNTRIES
3
SUPPLIERS
6
BUYERS
6
HHI
5,575
concentrated
Top 3 destination countries in Americas
1
United States (97.0%)
$355K
2
Venezuela (3.0%)
$11K
3
Dominican Republic (0.1%)
$220.96
Top 6 Indian suppliers into Americas
1
ALEMBIC PHARMACEUTICALS LTD
$255K
2
MYLAN LABORATORIES LTD
$100K
3
MEDWISE OVERSEAS PVT LTD
$11K
4
APOTHECON PHARMACEUTICALS PVT LTD
$868.09
5
DRREDDYS LABORATORIES LTD
$224.60
6
CIRON DRUGS AND PHARMACEUTICALS PVT LTD
$220.96
Top 5 Americas importers
1
J. KNIPPER & COMPANY · United States
$255K
2
MYLAN PHARMACEUTICALS INC · United States
$100K
3
EVERSANA LIFE SCIENCE SERVICES LLC · United States
$868.09
4
DR REDDYS LABORATORIES INC · United States
$224.60
5
MAXBIO PHARMA SRL · Dominican Republic
$220.96
Top 3 dosage forms
1
Injection
$266K
2
Tablet
$100K
3
Gel
$868.09
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 7 | $226K | $32K |
| Nov | 2 | $139K | $69K |
| Dec | 4 | $1K | $328.41 |
Shipment register · 13 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — ALEMBIC PHARMACEUTICALS LTD · 2 shipments · $255K | |||||||||||
| 1 | Oct 2025 | J. KNIPPER & COMPANY | United States | Injection | 22.1K | NOS | $5.73 | $127K | AHMEDABAD AIR | CHICAGO, IL | AIR |
| 2 | Nov 2025 | J. KNIPPER & COMPANY | United States | Injection | 21.8K | NOS | $5.86 | $128K | MUNDRA SEA | Norfolk | SEA |
| SUPPLIER #2 — MYLAN LABORATORIES LTD · 6 shipments · $100K | |||||||||||
| 3 | Oct 2025 | MYLAN PHARMACEUTICALS INC | United States | Tablet | 2.7M | NOS | $0.0089 | $24K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| 4 | Oct 2025 | MYLAN PHARMACEUTICALS INC | United States | Tablet | 1.5M | NOS | $0.011 | $17K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| 5 | Oct 2025 | MYLAN PHARMACEUTICALS INC | United States | Tablet | 5.1M | NOS | $0.0073 | $37K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| 6 | Oct 2025 | MYLAN PHARMACEUTICALS INC | United States | Tablet | 414.0K | NOS | $0.0094 | $4K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| 7 | Oct 2025 | MYLAN PHARMACEUTICALS INC | United States | Tablet | 576.0K | NOS | $0.0062 | $4K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| 8 | Oct 2025 | MYLAN PHARMACEUTICALS INC | United States | Tablet | 1.9M | NOS | $0.0078 | $15K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| SUPPLIER #3 — MEDWISE OVERSEAS PVT LTD · 1 shipments · $11K | |||||||||||
| 9 | Nov 2025 | UNKNOWN BUYER | Venezuela | Injection | 9.2K | NOS | $1.19 | $11K | AHMEDABAD AIR | CARACAS | AIR |
| SUPPLIER #4 — APOTHECON PHARMACEUTICALS PVT LTD · 2 shipments · $868.09 | |||||||||||
| 10 | Dec 2025 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | Gel | 5.8K | NOS | $0.049 | $282.59 | MUMBAI AIR (SAHAR) | CHICAGO O'HARE INT'L | AIR |
| 11 | Dec 2025 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | Gel | 11.2K | NOS | $0.052 | $585.50 | MUMBAI AIR (SAHAR) | CHICAGO O'HARE INT'L | AIR |
| SUPPLIER #5 — DRREDDYS LABORATORIES LTD · 1 shipments · $224.60 | |||||||||||
| 12 | Dec 2025 | DR REDDYS LABORATORIES INC | United States | Injection | 8.0K | NOS | $0.028 | $224.60 | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| SUPPLIER #6 — CIRON DRUGS AND PHARMACEUTICALS PVT LTD · 1 shipments · $220.96 | |||||||||||
| 13 | Dec 2025 | MAXBIO PHARMA SRL | Dominican Republic | Injection | 70.0K | NOS | $0.0032 | $220.96 | MUMBAI AIR (SAHAR) | SANTO DOMINGO | AIR |
10
PART VI — DRILL-DOWN · OCEANIA
Region: Oceania
1 countries · 1 shipments · $18.93 · 1 Indian suppliers · 1 buyers
SHIPMENTS
1
USD
$18.93
COUNTRIES
1
SUPPLIERS
1
BUYERS
1
HHI
10,000
concentrated
Top 1 destination countries in Oceania
1
Papua New Guinea (100.0%)
$18.93
Top 1 Indian suppliers into Oceania
1
NEON LABORATORIES LTD
$18.93
Top 1 Oceania importers
1
CITY PHARMACY LTD · Papua New Guinea
$18.93
Top 1 dosage forms
1
Injection
$18.93
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 0 | $0.0000 | — |
| Dec | 1 | $18.93 | $18.93 |
Shipment register · 1 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — NEON LABORATORIES LTD · 1 shipments · $18.93 | |||||||||||
| 1 | Dec 2025 | CITY PHARMACY LTD | Papua New Guinea | Injection | 360 | NOS | $0.053 | $18.93 | MUMBAI AIR (SAHAR) | PORT MORESBY | AIR |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 25 Indian diazepam exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped diazepam in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | AJANTA PHARMA LTD | MUMBAI | 5 | $320K | Tablet | Europe |
| 2 | ALEMBIC PHARMACEUTICALS LTD | GUJARAT | 2 | $255K | Injection | Americas |
| 3 | MYLAN LABORATORIES LTD | HYDERABAD | 6 | $100K | Tablet | Americas |
| 4 | NEON LABORATORIES LTD | ANDHERI [E] | 6 | $78K | Injection | Africa, Asia |
| 5 | KILITCH DRUGS (INDIA) LTD | MUMBAI | 9 | $43K | Injection, control, standard | Africa |
| 6 | SWISS PARENTERALS LTD | AHMEDABAD | 4 | $42K | Injection | Africa, Asia |
| 7 | STANMARC ENTERPRISE | MUMBAI | 1 | $40K | Injection | Africa |
| 8 | PHARMAX INDIA PVT LTD | MUMBAI | 1 | $35K | Solution | Africa |
| 9 | LABORATE PHARMACEUTICALS INDIA LTD | PANIPAT | 1 | $32K | Injection | Africa |
| 10 | AURA PHARMACEUTICALS PVT LTD | MUMBAI M S | 1 | $32K | Injection | Africa |
| 11 | VENOR PHARMA LTD | NEW DELHI | 5 | $24K | Tablet, Injection | Africa |
| 12 | CIRON DRUGS AND PHARMACEUTICALS PVT LTD | PALGHAR | 9 | $21K | Injection, Ampoule | Asia, Africa |
| 13 | NANDANI MEDICAL LABORATORIES PVT LTD | Indore | 1 | $16K | Injection | Africa |
| 14 | REKVINA PHARMACEUTICALS | BARODA | 4 | $12K | Tablet | Africa |
| 15 | CENTAUR PHARMACEUTICALS PVT LTD | MAPUSA | 1 | $12K | Tablet | Africa |
| 16 | MEDWISE OVERSEAS PVT LTD | AHMEDABAD | 1 | $11K | Injection | Americas |
| 17 | NEM LABORATORIES PVT LTD | MUMBAI | 2 | $9K | Injection | Africa |
| 18 | PSYCHOTROPICS INDIA LTD | ROORKEE | 1 | $9K | Injection | Asia |
| 19 | HUMANIQE BIOPHARMACEUTICALS PVT LTD | VISHAKHAPATNAM | 1 | $6K | Injection | Africa |
| 20 | SYNCOM FORMULATIONS (INDIA) LTD | Pithampur | 2 | $1K | Tablet | Africa |
| 21 | APOTHECON PHARMACEUTICALS PVT LTD | DIST- VADODARA | 2 | $868.09 | Gel | Americas |
| 22 | ALPA LABORATORIES LTD | INDORE | 2 | $711.76 | Injection | Africa |
| 23 | DRREDDYS LABORATORIES LTD | Medchel Malkajgiri | 1 | $224.60 | Injection | Americas |
| 24 | SHUKRA PHARMACEUTICALS LTD | AHMEDABAD | 2 | $1.19 | Injection | Africa |
| 25 | PSI CRO PHARMA INDIA PVT LTD | BANGALORE | 1 | $0.114 | Injection | Asia |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 33 global diazepam importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian diazepam in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | PLANET PHARMA SA | France | 5 | $320K | AJANTA PHARMA LTD | Tablet |
| 2 | J. KNIPPER & COMPANY | United States | 2 | $255K | ALEMBIC PHARMACEUTIC… | Injection |
| 3 | MYLAN PHARMACEUTICALS INC | United States | 6 | $100K | MYLAN LABORATORIES LTD | Tablet |
| 4 | ALABASS UNITED CO LTD | Sudan | 2 | $71K | NEON LABORATORIES LTD | Injection |
| 5 | CAISA PHARMA INTERNATIONALAV. BAKON | DR Congo | 1 | $40K | STANMARC ENTERPRISE | Injection |
| 6 | UNIQUE PHARMASTE UNION DE QUERIR | DR Congo | 1 | $35K | PHARMAX INDIA PVT LTD | Solution |
| 7 | NEW CESAMEX SARL | DR Congo | 1 | $32K | AURA PHARMACEUTICALS… | Injection |
| 8 | UNIQUE PHARMAAV. BAKONGO NO | DR Congo | 3 | $18K | VENOR PHARMA LTD | Tablet |
| 9 | CENTRALE DACHAT DES MEDICAMENTS | Burkina Faso | 1 | $16K | SWISS PARENTERALS LTD | Injection |
| 10 | SALAMA CENTRALE D ACHATS DE | Madagascar | 1 | $16K | NANDANI MEDICAL LABO… | Injection |
| 11 | AFRICHAHEL FARMACIA (SU) LDA,LOJA | Angola | 4 | $12K | REKVINA PHARMACEUTIC… | Tablet |
| 12 | GITTOES PHARMACEUTICALS LTD | Uganda | 1 | $12K | CENTAUR PHARMACEUTIC… | Tablet |
| 13 | AL-LILIUM DRUG STORE | Jordan | 1 | $11K | SWISS PARENTERALS LTD | Injection |
| 14 | GENERICS AND SPECIALITIES LDAVALE D | Mozambique | 2 | $9K | NEM LABORATORIES PVT… | Injection |
| 15 | IMMENSE CORP GROUP CO LTD | Cambodia | 1 | $9K | PSYCHOTROPICS INDIA … | Injection |
| 16 | CENTRALE DACHAT DE MEDICAMENTS ESS | Mauritania | 1 | $9K | SWISS PARENTERALS LTD | Injection |
| 17 | DAWA LTD | Kenya | 1 | $6K | CIRON DRUGS AND PHAR… | Injection |
| 18 | ARTEMIS PHARMACEUTICALS PTY LTD | South Africa | 1 | $6K | HUMANIQE BIOPHARMACE… | Injection |
| 19 | NEBULA TRADING CO LTD | Myanmar | 1 | $6K | SWISS PARENTERALS LTD | Injection |
| 20 | INSTITUTO NACIONAL DE FARMACIA E | Timor-Leste | 2 | $5K | CIRON DRUGS AND PHAR… | Injection, Ampoule |
| 21 | JORDAN ISLAMIC BANK | Jordan | 2 | $5K | NEON LABORATORIES LTD | Injection |
| 22 | YETICHEM DISTRIBUTORS PVT LTD | Nepal | 1 | $3K | NEON LABORATORIES LTD | Injection |
| 23 | LOTUS PHARMA | Burundi | 2 | $1K | SYNCOM FORMULATIONS … | Tablet |
| 24 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | 2 | $868.09 | APOTHECON PHARMACEUT… | Gel |
| 25 | RENE PHARMACY LTD | Kenya | 3 | $492.60 | CIRON DRUGS AND PHAR… | Injection |
| 26 | PRINCE PHARMA | DR Congo | 1 | $224.72 | VENOR PHARMA LTD | Tablet |
| 27 | DR REDDYS LABORATORIES INC | United States | 1 | $224.60 | DRREDDYS LABORATORIE… | Injection |
| 28 | MAXBIO PHARMA SRL | Dominican Republic | 1 | $220.96 | CIRON DRUGS AND PHAR… | Injection |
| 29 | CITY PHARMACY LTD | Papua New Guinea | 1 | $18.93 | NEON LABORATORIES LTD | Injection |
| 30 | ESTRO IMPORT AND EXPORT PVT LTD | Ethiopia | 4 | $2.06 | KILITCH DRUGS (INDIA… | control, standard, Tablet |
| 31 | VESTER PHARMACEUTICALS LTD | Ghana | 1 | $0.594 | SHUKRA PHARMACEUTICA… | Injection |
| 32 | SUCCESS PHARMACEUTICALS LTD | Ghana | 1 | $0.594 | SHUKRA PHARMACEUTICA… | Injection |
| 33 | LABCORP DEVELOPMENT (ASIA) PTE LTD | Singapore | 1 | $0.114 | PSI CRO PHARMA INDIA… | Injection |
This report covers 71 2025-Q4 Diazepam shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/diazepam
Talk to our trade analyst
Need a custom diazepam report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/diazepam
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Diazepam product page
Live data, supplier directory, price trends, and trade route analysis